Campbell & CO Investment Adviser LLC

Position in PFE — Pfizer Inc

CIK 1353570 BALTIMORE, MD

Position in PFE

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$1,808,383

-$456,944 QoQ

Shares Held

75,099

-17.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#1,007

of 2,821 holders

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Campbell & CO Investment Adviser LLC holds $29,426,907 across 9 Drug Manufacturers - General names. PFE ranks #7 (6.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMGN	Amgen Inc	18,379	$6,655,403
2	AZN	Astrazeneca PLC	29,025	$5,503,720
3	LLY	ELI LILLY & Co	3,682	$4,416,301
4	GSK	GSK plc	83,989	$4,402,703
5	SNY	Sanofi	52,949	$2,258,804
6	GILD	Gilead Sciences, Inc.	17,781	$2,246,451
7	PFE	Pfizer Inc This page	75,099	$1,808,383
8	BMY	Bristol Myers Squibb Co	23,327	$1,344,101

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,808,383	75,099	-17.5%	Shares	Sole	2026-08-03
2025-12-31	$2,265,327	90,977	-31.4%	Shares	Sole	2026-02-12
2025-09-30	$3,376,711	132,524	+824.7%	Shares	Sole	2025-10-28
2025-06-30	$347,407	14,332	-75.2%	Shares	Sole	2025-08-07
2025-03-31	$1,463,790	57,766	+661.1%	Shares	Sole	2025-05-14
2024-12-31	$201,362	7,590	-90.8%	Shares	Sole	2025-02-10
2024-09-30	$2,387,434	82,496	+99.3%	Shares	Sole	2024-11-12
2024-03-31	$1,148,850	41,400	+430.0%	Shares	Sole	2024-05-10
2022-12-31	$400,286	7,812	-9.8%	Shares	Sole	2023-02-14
2022-09-30	$378,917	8,659	-55.7%	Shares	Sole	2022-11-14
2021-09-30	$840,845	19,550	+77.7%	Shares	Sole	2021-11-10
2021-06-30	$430,760	11,000	—	Shares	Sole	2021-08-11
No filing history on record for this holder in this stock.